Research & Innovation

Although peripheral nerves can regenerate after injury, recovery is often poor in the elderly, in people with conditions such as diabetes, or after particularly severe trauma. The vascular system actively supports nerve repair by shaping the healing environment and protecting neural tissue through...

Treatment-resistant depression, substance use disorders, anxiety disorders: for some psychiatric conditions, existing therapies do not always suffice. It is precisely from this unmet therapeutic need that neuropharmacology research has, in recent years, been living what researchers call the...

Riccardo Federico Visconti graduated in Dentistry and Dental Prosthetics at Vita-Salute San Raffaele University (UniSR) and trained in implantology. A decade later, his multicentre randomised clinical trial was selected as a finalist for the best scientific contribution at the Academy of...

Loss of pulse is the most critical signal of cardiac arrest. According to the American Red Cross, survival odds fall by 10% for every minute CPR and defibrillation are delayed. Every year, millions of people worldwide die from cardiac arrest, and nearly half of all events occur without witnesses,...

The gene responsible for thalassemia was identified with precision by the late 1980s. That early clarity made thalassemia gene therapy one of the first candidates for direct DNA intervention, and decades of research have since moved it from laboratory hypothesis to approved therapy. Two advanced...

The Marie Curie fellowship, officially the Marie Skłodowska-Curie Actions (MSCA), is the European Union’s principal funding instrument for researcher mobility. In 2024, the call for MSCA Postdoctoral Fellowships alone received 10,360 proposals from across the world, with a budget allocated to...

Choosing a career in immunology means embracing a discipline in constant evolution. New diseases are being described, established ones reclassified, and the therapeutic landscape — from monoclonal antibodies to cytokine inhibitors and the adoptive cell therapies like CAR-T — is expanding at a pace...

In the United States and several European regions, colorectal cancer incidence among adults under 50 has been rising steadily. This age group was long considered low-risk, yet it now accounts for roughly 10–15% of new diagnoses, and the underlying causes remain largely unknown. «In Italy, this...

Eight in ten young oncologists in Italy show signs of burnout, according to 2025 data from AIOM, the Italian Association of Medical Oncology. The problem is not purely organizational. Among the main contributing factors: difficulty managing communication with patients and families, and a lack of...